SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 5 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,161,000 | +141.0% | 375,500 | +146.7% | 0.01% | +100.0% |
| Q1 2016 | $2,971,000 | +69.6% | 152,200 | +235.2% | 0.00% | +100.0% |
| Q4 2015 | $1,752,000 | +1.8% | 45,400 | -15.3% | 0.00% | 0.0% |
| Q3 2015 | $1,721,000 | +21.6% | 53,600 | +15.3% | 0.00% | +100.0% |
| Q2 2015 | $1,415,000 | +215.1% | 46,500 | +37.6% | 0.00% | – |
| Q1 2015 | $449,000 | -46.0% | 33,800 | -41.2% | 0.00% | -100.0% |
| Q4 2014 | $832,000 | -41.5% | 57,500 | -14.7% | 0.00% | 0.0% |
| Q3 2014 | $1,422,000 | +69.3% | 67,400 | +139.0% | 0.00% | 0.0% |
| Q2 2014 | $840,000 | -57.1% | 28,200 | -65.4% | 0.00% | -50.0% |
| Q1 2014 | $1,958,000 | +22.5% | 81,500 | +3.8% | 0.00% | 0.0% |
| Q4 2013 | $1,599,000 | -46.0% | 78,500 | +25.2% | 0.00% | -60.0% |
| Q3 2013 | $2,961,000 | +41.2% | 62,700 | +13.8% | 0.01% | +25.0% |
| Q2 2013 | $2,097,000 | – | 55,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 50,000 | $6,061,000 | 0.84% |
| Worth Venture Partners, LLC | 11,200 | $170,957 | 0.10% |
| GROUP ONE TRADING, L.P. | 196,700 | $23,843,974 | 0.08% |
| SIMPLEX TRADING, LLC | 236,200 | $28,632 | 0.02% |
| Twin Tree Management, LP | 41,700 | $5,054,874 | 0.01% |
| JPMORGAN CHASE & CO | 661,800 | $80,223,396 | 0.01% |
| JANE STREET GROUP, LLC | 198,400 | $24,050,048 | 0.01% |
| IMC-Chicago, LLC | 23,400 | $2,836,548 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |